Broadening the spectrum of NTRK rearranged mesenchymal tumors and usefulness of pan-TRK immunohistochemistry for identification of NTRK fusionsIva Brčić, Bernadette Liegl‐Atzwanger, Theresa Godschachner et al.|Modern Pathology|2020Cited by 99
Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targetsEllen Heitzer, Bernadette Liegl‐Atzwanger, Sandra Sunitsch et al.|Modern Pathology|2017Cited by 41
Undifferentiated round cell sarcomas with CIC-DUX4 gene fusion: expanding the clinical spectrumIva Brčić, Bernadette Liegl‐Atzwanger, Thomas Brodowicz et al.|Pathology|2019Cited by 41
Clinical implementation of plasma cell-free circulating tumor DNA quantification by digital droplet PCR for the monitoring of Ewing sarcoma in children and adolescentsMarkus G. Seidel, Ellen Heitzer, Karl Kashofer et al.|Frontiers in Pediatrics|2022Cited by 23
New Insights from Long-Term Clinical Use of Circulating Tumor DNA-Based Minimal Residual Disease Monitoring in Translocation-Associated SarcomasSophie Joch, Markus G. Seidel, Maria Anna Smolle et al.|Oncology Research and Treatment|2024Cited by 2